In its early years, GoFundMe funded honeymoon trips, graduation gifts, and church missions to overseas hospitals in need. Now it has become a go-to platform for patients trying to escape medical billing nightmares.
|
ERIC HARKLEROAD/KFF HEALTH NEWS
Patents to extend monopolies, manufacturers agreements to use expensive branded drugs in combination pills and other tactics are costing U.S. consumers
To keep revenues high, insurance companies appear increasingly likely to employ computer algorithms or people with little relevant experience to issue rapid-fire denials of claims
Booster shots are likely to be here before long because of the outdated, 60-year-old basic standard the Food and Drug Administration uses to authorize medicines for sale.
Scientists may have to wait many years to find out whether Aduhelm is actually effective because the drug was approved using FDA's accelerated pathway.
Jul 13, 2021
Image
A medical laboratory scientist in Seattle reviews samples of purified genetic material to detect COVID-19 cases.
|
DAN DELONG/KAISER HEALTH NEWS
China has great scientists, but they work for an authoritarian government where politics always comes first, making it dangerous to reveal something that makes China look bad.
Many of the new types of telemedicine being promoted by start-ups more clearly benefit providers’ and investors’ pockets, rather than yielding more high-quality and cost-effective medicine for patients.
May 6, 2021
Image
World Trade Center memorial./Ged Lawson via Unsplash.com
After 9/11, the United States rapidly shifted resources to create a massive infrastructure to ferret out and combat terrorism while forgetting that terrorism of nature can be equally deadly.
The Biden administration’s much-needed national strategy to end the covid-19 pandemic includes plans to remedy the chaotic vaccination effort with “more people, more places, more supply.”